In October 2020 the first International Ewing’s sarcoma Symposium was held virtually due to the Covid pandemic. It was hosted by our good friends the Bone Cancer Research Trust (‘BCRT’) and Professor Sue Burchill from the University of Leeds; the symposium was such a success that the above follow up event was held in a year later.
This year’s virtual conference brought together over 100 researchers from across the world and attendees enjoyed fifteen presentations; some of which were followed by group discussions to exchange ideas and promote opportunities for collaboration.
The presentations and discussions were centred around four key topics:
- How genomic studies can help us identify novel targeted therapies for Ewing sarcoma.
- Immunology approaches for the treatment of Ewing sarcoma.
- The microenvironment of Ewing sarcoma tumours.
- Research models and the use of patient derived samples to develop novel therapies for Ewing sarcoma.
The event concluded with the announcement of plans for next year’s event to be held in October, hopefully in person.
ESRT wish to congratulate BCRT and Professor Burchill for bringing such a large, diverse group of researchers together for a single event, which ran like clockwork.
It is so pleasing to know that so many researchers are working so hard to improve treatments into Ewing’s sarcoma. But research costs money and that’s why ESRT is so grateful to everyone that supports our charity to help fund this important research along with our allies at BCRT who we regularly collaborate with.